Fred N. Eshelman

530 total citations
19 papers, 428 citations indexed

About

Fred N. Eshelman is a scholar working on Pharmacology, Oncology and Analytical Chemistry. According to data from OpenAlex, Fred N. Eshelman has authored 19 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Oncology and 5 papers in Analytical Chemistry. Recurrent topics in Fred N. Eshelman's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). Fred N. Eshelman is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). Fred N. Eshelman collaborates with scholars based in United States. Fred N. Eshelman's co-authors include Dyal C. Garg, Donald J. Weidler, Daniel A. Spyker, Michael Peters, Charles T. Richardson, D. Craig Brater, J. Robert Powell, John D. Hurley, Roger L. Gebhard and John H. Eckfeldt and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Pediatrics and Clinical Pharmacology & Therapeutics.

In The Last Decade

Fred N. Eshelman

18 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred N. Eshelman United States 13 132 94 89 81 71 19 428
Yoshiro Tomono Japan 8 123 0.9× 60 0.6× 84 0.9× 50 0.6× 121 1.7× 23 426
CG Regardh Sweden 9 68 0.5× 52 0.6× 83 0.9× 52 0.6× 67 0.9× 10 328
Parviz Mojaverian United States 18 117 0.9× 68 0.7× 90 1.0× 113 1.4× 129 1.8× 41 886
Ramanuj Achari United States 14 57 0.4× 49 0.5× 60 0.7× 110 1.4× 203 2.9× 44 904
Jnan R. Saha United States 9 139 1.1× 58 0.6× 118 1.3× 65 0.8× 46 0.6× 12 672
F. O. Müller South Africa 15 130 1.0× 33 0.4× 95 1.1× 73 0.9× 85 1.2× 60 598
John A. Romankiewicz United States 12 94 0.7× 63 0.7× 68 0.8× 44 0.5× 207 2.9× 23 783
R. Wayne Frost United States 12 323 2.4× 105 1.1× 52 0.6× 118 1.5× 63 0.9× 16 589
J. Nimmo United Kingdom 11 129 1.0× 98 1.0× 229 2.6× 97 1.2× 227 3.2× 16 916
J. V. Willis United Kingdom 12 341 2.6× 89 0.9× 154 1.7× 60 0.7× 63 0.9× 14 622

Countries citing papers authored by Fred N. Eshelman

Since Specialization
Citations

This map shows the geographic impact of Fred N. Eshelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred N. Eshelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred N. Eshelman more than expected).

Fields of papers citing papers by Fred N. Eshelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred N. Eshelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred N. Eshelman. The network helps show where Fred N. Eshelman may publish in the future.

Co-authorship network of co-authors of Fred N. Eshelman

This figure shows the co-authorship network connecting the top 25 collaborators of Fred N. Eshelman. A scholar is included among the top collaborators of Fred N. Eshelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred N. Eshelman. Fred N. Eshelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Comstock, Thomas J., Domenic A. Sica, Antonia Harford, & Fred N. Eshelman. (1989). Ranitidine Bioavailability and Disposition Kinetics in Patients Undergoing Chronic Hemodialysis. ˜The œNephron journals/Nephron journals. 52(1). 15–19. 4 indexed citations
2.
Sica, Domenic A., Thomas J. Comstock, Antonia Harford, & Fred N. Eshelman. (1987). Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis. European Journal of Clinical Pharmacology. 32(6). 587–591. 20 indexed citations
3.
Garg, Dyal C., et al.. (1986). Pharmacokinetics of Ranitidine in Patients With Renal Failure. The Journal of Clinical Pharmacology. 26(4). 286–291. 24 indexed citations
4.
Blumer, Jeffrey L., Fred C. Rothstein, Barbara Kaplan, et al.. (1985). Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease. The Journal of Pediatrics. 107(2). 301–306. 37 indexed citations
5.
Holtzman, Jordan L., et al.. (1985). The effects of several weeks of ethanol consumption on ethanol kinetics in normal men and women. Clinical Pharmacology & Therapeutics. 38(2). 157–163. 37 indexed citations
6.
Rocci, Mario L., et al.. (1985). Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone. Clinical Pharmacology & Therapeutics. 37(5). 534–538. 14 indexed citations
7.
Garg, Dyal C., Fred N. Eshelman, & Donald J. Weidler. (1985). Pharmacokinetics of Ranitidine Following Oral Administration With Ascending Doses and With Multiple‐Fixed Doses. The Journal of Clinical Pharmacology. 25(6). 437–443. 32 indexed citations
8.
Holloway, R. H., et al.. (1984). Effects of Ranitidine and of Cimetidine on Pentagastrin-Stimulated Gastric Acid Secretion. Obstetric Anesthesia Digest. 4(3). 92–92. 5 indexed citations
9.
Smith, A. Ian, et al.. (1984). Ranitidine disposition and systemic availability in hepatic cirrhosis. Clinical Pharmacology & Therapeutics. 35(4). 487–494. 20 indexed citations
10.
Greenblatt, David J., et al.. (1984). Ranitidine does not impair oxidative or conjugative metabolism: Noninteraction with antipyrine, diazepam, and lorazepam. Clinical Pharmacology & Therapeutics. 35(2). 188–192. 24 indexed citations
11.
Powell, J. Robert, et al.. (1984). The Influence of H2‐Receptor Antagonists on Steady‐State Concentrations of Propranolol and 4‐Hydroxypropranolol. The Journal of Clinical Pharmacology. 24(11). 500–508. 23 indexed citations
12.
Eshelman, Fred N., et al.. (1984). The Effects of Antacid and Propantheline on the Absorption of Oral Ranitidine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 4(2). 89–92. 2 indexed citations
13.
Powell, J. Robert, John F. Rogers, William A. Wargin, Robert E. Cross, & Fred N. Eshelman. (1984). Inhibition of Theophylline Clearance by Cimetidine but not Ranitidine. Survey of Anesthesiology. 28(5). 371–371. 2 indexed citations
14.
Garg, Dyal C., Donald J. Weidler, & Fred N. Eshelman. (1983). Ranitidine bioavailability and kinetics in normal male subjects. Clinical Pharmacology & Therapeutics. 33(4). 445–452. 81 indexed citations
15.
Brater, D. Craig, Michael Peters, Fred N. Eshelman, & Charles T. Richardson. (1982). Clinical comparison of cimetidine and ranitidine. Clinical Pharmacology & Therapeutics. 32(4). 484–489. 32 indexed citations
16.
Hurley, John D. & Fred N. Eshelman. (1980). Trimethobenzamide HCI in the Treatment of Nausea and Vomiting Associated with Antineoplastic Chemotherapy. The Journal of Clinical Pharmacology. 20(5-6). 352–356. 14 indexed citations
17.
Eshelman, Fred N. & Daniel A. Spyker. (1978). Pharmacokinetics of Amoxicillin and Ampicillin: Crossover Study of the Effect of Food. Antimicrobial Agents and Chemotherapy. 14(4). 539–543. 48 indexed citations
18.
Eshelman, Fred N., et al.. (1976). A Case of Propoxyphene Overdose and Death. Drug Intelligence & Clinical Pharmacy. 10(10). 596–597.
19.
Eshelman, Fred N.. (1975). Clinical Pharmacy Defined. Drug Intelligence & Clinical Pharmacy. 9(12). 668–668. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiro Tomono Breakdown of academic impact, for papers by CG Regardh Breakdown of academic impact, for papers by Parviz Mojaverian Breakdown of academic impact, for papers by Ramanuj Achari Breakdown of academic impact, for papers by Jnan R. Saha Breakdown of academic impact, for papers by F. O. Müller Breakdown of academic impact, for papers by John A. Romankiewicz Breakdown of academic impact, for papers by R. Wayne Frost Breakdown of academic impact, for papers by J. Nimmo Breakdown of academic impact, for papers by J. V. Willis
Rankless by CCL
2026